Related Experiment Video
Updated: Jun 1, 2026

05:13
Establishment of an Embryo Implantation Model In Vitro
Published on: June 21, 2024
Body mass index impacts in vitro fertilization stimulation
Micah J Hill1, Steve Hong, John L Frattarelli
1Eunice Kennedy Shriver National Institute of Child Health and Human Development, 10 Center Drive, Bethesda, MD 20892, USA.
ISRN Obstetrics and Gynecology
|June 4, 2011
Summary
Body Mass Index (BMI) did not predict live birth rates in IVF patients. However, higher BMI correlated with more follicles stimulated and less gonadotropin medication needed for successful IVF treatment.
Area of Science:
- Reproductive Endocrinology
- In Vitro Fertilization (IVF)
Background:
- Obesity, indicated by Body Mass Index (BMI), is a growing concern in reproductive health.
- Understanding the impact of BMI on In Vitro Fertilization (IVF) outcomes is crucial for patient counseling and treatment optimization.
Purpose of the Study:
- To prospectively investigate whether Body Mass Index (BMI) is a predictive factor for live birth rates in patients undergoing IVF.
- To analyze the correlation between BMI and various parameters of IVF treatment, including follicle stimulation and gonadotropin dosage.
Main Methods:
- A prospective study involving 117 infertility patients undergoing IVF.
- Primary outcome measure was IVF success rates, with secondary analysis of BMI correlations with follicle count, gonadotropin usage, and stimulation duration.
Main Results:
- Mean BMI did not significantly differ between patients with successful and unsuccessful IVF outcomes.
- A significant positive correlation was observed between BMI and the number of stimulated follicles (r = 0.19, P < .05).
- Significant negative correlations were found between BMI and the amount of gonadotropins used (r = -0.25, P < .01) and duration of stimulation (r = -0.19, P < .05).
Conclusions:
- Elevated BMI in women undergoing IVF is associated with increased follicle production and requires less gonadotropin medication and shorter stimulation periods.
- Despite these physiological differences, Body Mass Index (BMI) was not found to be a significant predictor of live birth rates in this cohort of IVF patients.
Related Concept Videos
In Vitro Fertilization
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
Meiosis II
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
Fertilization
During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
Spermatogenesis
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
